Urokinase-type plasminogen activator receptor promotes proliferation and invasion with reduced cisplatin sensitivity in malignant mesothelioma
Open Access
- 2 September 2016
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (43) , 69565-69578
Abstract
Urokinase-type plasminogen activator receptor promotes proliferation and invasion with reduced cisplatin sensitivity in malignant mesotheliomaKeywords
This publication has 55 references indexed in Scilit:
- Lipoprotein Receptor–Related Protein 1 Regulates Collagen 1 Expression, Proteolysis, and Migration in Human Pleural Mesothelial CellsAmerican Journal of Respiratory Cell and Molecular Biology, 2012
- Diameter and rigidity of multiwalled carbon nanotubes are critical factors in mesothelial injury and carcinogenesisProceedings of the National Academy of Sciences of the United States of America, 2011
- The Urokinase Receptor Supports Tumorigenesis of Human Malignant Pleural Mesothelioma CellsAmerican Journal of Respiratory Cell and Molecular Biology, 2010
- uPAR induces epithelial–mesenchymal transition in hypoxic breast cancer cellsJournal of Cell Biology, 2007
- uPAR-induced cell adhesion and migration: vitronectin provides the keyJournal of Cell Biology, 2007
- AKT/PKB Signaling: Navigating DownstreamCell, 2007
- Identification of uPAR-positive Chemoresistant Cells in Small Cell Lung CancerPLOS ONE, 2007
- Perturbations of the AKT signaling pathway in human cancerOncogene, 2005
- Cisplatin: mode of cytotoxic action and molecular basis of resistanceOncogene, 2003
- Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapyLeukemia, 2003